Conditions: Diabetes Mellitus, Type 2
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 275
Healthy volunteers: no

Brief summary:
This trial will compare the use of fixed dose combination of empagliflozin and linagliptin to linagliptin alone in patient with type 2 diabetes mellitus

Detailed description:

Arms:
arm 1: patient to receive 5 mg linagliptin once daily arm 2: patient to receive one tablet once daily arm 3: patient to receive one tablet once daily arm 4: None arm 5: None arm 6: None

Interventions: intervention 1: Linagliptin intervention 2: Empagliflozin placebo + linagliptin placebo low dose intervention 3: Empagliflozin + linagliptin low dose intervention 4: Linagliptin placebo intervention 5: Empagliflozin + linagliptin high dose intervention 6: Empa + lina highdose placebo
Intervention descriptions: intervention 1: None intervention 2: Matching placebo empagliflozin + linagliptin intervention 3: tablet intervention 4: Matching placebo linagliptin intervention 5: tablet intervention 6: None

Protocol document: